Categories: News

L7|ESP™ to Support Genome Engineering at Washington University

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

AUSTIN, Texas, Aug. 31, 2021 /PRNewswire/ — L7 Informatics is honored to announce the roll-out of  L7|ESP at the Genome Engineering & iPSC Center (GEiC) at Washington University in St. Louis. The center helps the university’s researchers develop cell and animal models using gene editing and stem cell technologies. The full implementation of the L7|ESP platform facilitates data management and process automation of all lab operations, including sequencing, bioinformatics, request management, and billing and invoicing.

“We are honored to support GEiC and enhance their services in the fields of genome engineering and stem cell research,” said Vasu Rangadass, President and CEO of L7 Informatics.

L7|ESP is a unified platform with a single data fabric that digitalizes and automates scientific business processes. The platform fosters automation, collaboration and expedites scientific discoveries by managing scientific knowledge, processes, and data in one place. L7|ESP’s functionality enables GEiC to manage and track its projects, samples, instrument integrations, and key scientific data.

“We will use the L7 technology to track and manage diverse research projects that employ gene editing and stem cell technologies,” said Xiaoxia Cui, PhD., Assistant Professor and Director of GEiC at Washington University in St. Louis.

About L7 Informatics, Inc.
The L7 mission is to revolutionize scientific processes and data management to accelerate precision health across life sciences, healthcare, and nutrition value chains. L7 Informatics offers end-to-end solutions and services enabling researchers to make new genomics discoveries, precision therapeutics manufacturers to create higher fidelity therapies, health systems to provide superior diagnostics and standard of care, and precision agriculture to meet tomorrow’s needs. To learn more, please visit http://www.l7informatics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/l7esp-to-support-genome-engineering-at-washington-university-301366174.html

SOURCE L7 Informatics

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare
AddThis Website Tools
Staff

Recent Posts

Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance

Designed to address increasing demand for advanced medical connectors in growing specialties such as electrophysiology…

1 hour ago

Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance

Designed to address increasing demand for advanced medical connectors in growing specialties such as electrophysiology…

1 hour ago

ForeSee Medical and Vim Announce Strategic Partnership to Enhance Risk Adjustment and Streamline Provider Workflows

SAN DIEGO--(BUSINESS WIRE)--ForeSee Medical Inc., a leading AI-powered risk adjustment software company, and Vim, a…

1 hour ago

ForeSee Medical and Vim Announce Strategic Partnership to Enhance Risk Adjustment and Streamline Provider Workflows

SAN DIEGO--(BUSINESS WIRE)--ForeSee Medical Inc., a leading AI-powered risk adjustment software company, and Vim, a…

1 hour ago

Butterfly Network’s RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment

Oeko-Institut appointed for third-party evaluation; stakeholder consultation will run June 6, 2025 - August 1,…

1 hour ago

Ambio Life Sciences Launches World’s First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions

Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized…

1 hour ago